Facebook
Twitter
Telegram
Report an ErrorInovio Pharmaceuticals Financial Ratios 2011-2024 | INO
Annual Financial Ratios Inovio Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -0.1 | -0.2 | -10.3 | -3.9 | -4.8 | -4.4 | -6.1 | -15.6 | -13.7 | -7.3 | -4.4 | -4.7 |
P/S |
264.6 | 2.4 | 31.8 | 232.3 | 111.9 | 15.3 | 9.1 | 12.7 | 11.2 | 47.2 | 36.0 | 21.2 | 7.3 |
EPS |
-6.1 | -14.1 | -17.4 | -1.1 | -1.2 | -1.1 | -1.1 | -1.0 | -0.4 | -0.6 | -1.4 | -0.6 | -0.1 |
EV (Enterprise Value) |
259 M | 104 M | 81.5 M | 1.55 B | 576 M | 487 M | 407 M | 481 M | 436 M | 473 M | 487 M | 92 M | 67.9 M |
EBITDA per Share |
-6.37 | -13.3 | -17.1 | -0.78 | -1.07 | -0.963 | -0.993 | -1.01 | -0.489 | -0.641 | -0.422 | -0.664 | -0.64 |
EV/EBITDA |
-2.2 | 1.8 | -4.9 | -5.0 | -4.5 | -5.8 | -11.9 | -11.9 | -23.2 | -3.6 | -2.7 | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.6 | -0.25 | 1.73 | -0.63 | -0.05 | 0.53 | 0.24 | -0.05 | -0.27 | 0.16 |
P/B |
1.9 | 0.1 | 0.1 | 3.7 | 85.1 | 5.4 | 2.7 | 3.6 | 2.6 | 4.4 | 9.2 | 2.5 | 1.5 |
P/CF |
-1.8 | -0.1 | -0.3 | -9.7 | -4.7 | -6.2 | -5.3 | -6.8 | -29.9 | -15.8 | -31.2 | -3.9 | -3.6 |
ROE % |
-115.14 | -125.84 | -75.98 | -36.09 | -2208.37 | -111.42 | -61.90 | -59.77 | -16.59 | -32.39 | -124.81 | -56.43 | -31.87 |
ROA % |
-79.04 | -80.28 | -61.23 | -30.83 | -82.92 | -73.96 | -47.11 | -42.45 | -13.65 | -27.41 | -74.79 | -43.57 | -24.96 |
ROCE % |
-122.66 | -120.33 | -75.37 | -26.91 | -99.24 | -98.20 | -55.75 | -59.47 | -19.35 | -33.54 | -36.32 | -67.04 | -44.39 |
Current Ratio |
3.2 | 2.8 | 5.2 | 6.9 | 2.9 | 2.5 | 3.9 | 2.8 | 5.5 | 7.1 | 2.0 | 1.9 | 2.9 |
DSO |
- | - | 1908.5 | 474.3 | 180.4 | 48.6 | 56.1 | 171.0 | 66.0 | 97.9 | 89.5 | 76.8 | 18.9 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 1908.5 | 474.3 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | 1908.5 | 474.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Inovio Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.31 | - | -0.13 | -0.13 | -1.89 | - | -0.15 | -0.46 | -0.36 | - | -0.29 | -0.39 | -0.27 | -0.14 | 0.12 | -0.83 | -0.26 | -0.38 | -0.23 | -0.3 | -0.3 | -0.34 | -0.27 | -0.07 | -0.36 | -0.24 | -0.39 | -0.13 | -0.31 | -0.35 | -0.28 | -0.26 | -0.11 | -0.25 | 0.08 | -0.09 | -0.17 | -0.12 | -0.12 | -0.18 | -0.2 | -0.3 | -0.64 | -0.24 | -0.23 | - | -0.05 | -0.03 | -0.06 | -0.04 | -0.04 | -0.02 | -0.02 |
EBITDA per Share |
-1.33 | - | - | - | -2.01 | - | -0.13 | -0.43 | -0.32 | - | -0.28 | -0.39 | -0.26 | -0.16 | -0.21 | -0.2 | -0.2 | -0.3 | -0.21 | -0.27 | -0.28 | -0.3 | -0.26 | -0.04 | -0.35 | -0.25 | -0.32 | -0.11 | -0.29 | -0.3 | -0.26 | -0.24 | -0.21 | -0.2 | 0.06 | -0.22 | -0.13 | -0.18 | -0.13 | -0.16 | -0.18 | -0.15 | 0.02 | -0.12 | -0.17 | -0.04 | -0.05 | -0.05 | -0.03 | -0.04 | -0.05 | -0.04 | -0.04 |
ROE % |
-102.36 | -65.94 | -80.11 | -69.72 | -85.19 | -72.89 | -86.15 | -85.25 | -64.95 | -38.77 | -44.05 | -26.63 | -38.38 | -36.09 | -1127.20 | -1803.55 | -2631.14 | -3474.70 | -2416.22 | -1772.80 | -924.94 | -111.54 | -88.73 | -83.92 | -82.94 | -61.95 | -68.12 | -60.99 | -69.50 | -59.81 | -48.75 | -28.73 | -17.11 | -16.61 | -13.06 | -22.70 | -28.77 | -32.48 | -55.27 | -107.69 | -118.75 | -125.88 | -98.33 | -58.74 | -50.08 | -57.25 | -66.91 | -57.23 | -51.17 | -32.24 | -9.60 | -5.96 | -5.10 |
ROA % |
-73.99 | -48.07 | -57.71 | -49.78 | -58.14 | -51.01 | -62.24 | -63.83 | -54.09 | -33.42 | -37.93 | -23.14 | -33.11 | -30.83 | -52.48 | -72.08 | -68.65 | -82.92 | -81.89 | -84.93 | -69.58 | -73.96 | -60.30 | -59.45 | -59.45 | -47.11 | -50.72 | -44.45 | -50.15 | -42.45 | -35.74 | -21.18 | -13.33 | -13.65 | -10.88 | -18.94 | -24.15 | -27.41 | -39.29 | -68.82 | -72.98 | -74.79 | -58.74 | -38.44 | -35.30 | -43.57 | -51.08 | -43.84 | -39.30 | -24.96 | -7.43 | -4.62 | -3.95 |
ROCE % |
-106.67 | -69.67 | -83.07 | -70.75 | -83.86 | -68.59 | -81.81 | -81.62 | -63.00 | -38.61 | -44.98 | -39.64 | -30.47 | -26.91 | -906.14 | -1595.53 | -2409.29 | -3234.51 | -2382.85 | -1716.23 | -901.25 | -108.23 | -90.37 | -80.22 | -81.00 | -58.74 | -60.81 | -56.69 | -64.71 | -61.84 | -51.97 | -33.46 | -27.28 | -19.51 | -21.15 | -30.76 | -31.28 | -35.51 | -40.87 | -31.92 | -33.60 | -37.26 | -40.13 | -59.90 | -68.85 | -68.39 | -62.47 | -57.55 | -48.65 | -45.73 | -13.39 | -10.86 | -9.27 |
Current Ratio |
3.7 | 3.2 | 3.5 | 3.7 | 4.0 | 2.8 | 3.1 | 2.8 | 4.9 | 5.2 | 6.5 | 7.1 | 8.9 | 6.9 | 6.9 | 6.9 | 6.9 | 1.0 | 1.0 | 1.0 | 1.0 | 3.0 | 3.0 | 3.0 | 3.0 | 4.2 | 4.2 | 4.2 | 4.2 | 3.5 | 3.5 | 3.5 | 3.5 | 5.6 | 5.6 | 5.6 | 5.6 | 6.5 | 6.5 | 6.5 | 6.5 | 2.5 | 2.5 | 2.5 | 2.5 | 4.4 | 4.4 | 4.4 | 4.4 | 4.6 | 4.6 | 4.6 | 4.6 |
DSO |
- | - | - | - | 704.6 | - | 34.5 | 493.6 | 2170.5 | - | 2799.6 | 3853.1 | 1688.7 | 1818.8 | 1888.7 | 1586.7 | 2109.5 | 108.7 | 100.2 | 84.6 | 292.9 | 120.9 | 535.6 | 583.6 | 278.0 | 62.3 | 207.1 | 26.8 | 96.0 | 169.6 | 115.1 | 232.7 | 130.1 | 112.5 | 27.7 | 126.6 | 89.5 | 104.1 | 139.0 | 67.3 | 118.2 | 173.2 | 31.8 | 383.5 | 129.6 | 66.8 | 88.7 | 173.8 | 35.0 | 26.1 | 16.2 | 17.6 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 704.6 | - | 34.5 | 493.6 | 2170.5 | - | 2799.6 | 3853.1 | 1688.7 | 1818.8 | 1888.7 | 1586.7 | 2109.5 | 108.7 | 100.2 | 84.6 | 292.9 | 120.9 | 535.6 | 583.6 | 278.0 | 62.3 | 207.1 | 26.8 | 96.0 | 169.6 | 115.1 | 232.7 | 130.1 | 112.5 | 27.7 | 126.6 | 89.5 | 104.1 | 139.0 | 67.3 | 118.2 | 173.2 | 31.8 | 383.5 | 129.6 | 66.8 | 88.7 | 173.8 | 35.0 | 26.1 | 16.2 | 17.6 | - |
Cash Conversion Cycle |
- | - | - | - | 704.6 | - | 34.5 | 493.6 | 2170.5 | - | 2799.6 | 3853.1 | 1688.7 | 1818.8 | 1888.7 | 1586.7 | 2109.5 | 108.7 | 100.2 | 84.6 | 292.9 | 120.9 | 535.6 | 583.6 | 278.0 | 62.3 | 207.1 | 26.8 | 96.0 | 169.6 | 115.1 | 232.7 | 130.1 | 112.5 | 27.7 | 126.6 | 89.5 | 104.1 | 139.0 | 67.3 | 118.2 | 173.2 | 31.8 | 383.5 | 129.6 | 66.8 | 88.7 | 173.8 | 35.0 | 26.1 | 16.2 | 17.6 | - |
All numbers in USD currency